• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 764

Rebaudioside D

Intended Use: For use as a general purpose sweetening agent in foods, excluding infant formula and products under USDAs jurisdiction, at levels determined by good manufacturing practices (GMP)
Basis: Scientific procedures
Notifier: Sichuan Ingia Biosynthetic Co., Ltd.
Notifier Address: Room 7-701#, Tongwei International Centre, No., 588
Central Tianfu Avenue, High-tech Zone
Chengdu, Sichuan Province
GRAS Notice (releasable information): GRN 764 (in PDF) (8.5 MB)
Date of closure: Jul 10, 2018
FDA's Letter: FDA has no questions (in PDF) (111 kB)